The Diagnostic and Prognostic Potential of Serum Taurine and PUMA in Staging Colorectal Cancer Patients

Key Points

• The research aims to evaluate serum taurine and PUMA as diagnostic and prognostic biomarkers for colorectal cancer.
• Analyzed serum levels of taurine and PUMA in patients with colorectal cancer.
• Compared levels in colorectal cancer patients to control groups.
• Assessed potential for non-invasive screening and prognostic evaluation.
• PUMA shows promise as a prognostic indicator for colorectal cancer.
• Taurine levels may assist in diagnosing colorectal cancer.
• Findings indicate a need for further research into these biomarkers within the Egyptian population.